The four products were manufactured at a plant cited by FDA for deficiencies in Good Manufacturing Practices. Posted 05/30/2010
Continue reading...28. May 2010
Comments Off
Products sold under the Claris, Sagent Pharmaceuticals, Pfizer, and West-Ward Pharmaceuticals labels. Reports of floating matter in intravenous bags of metronidazole and ondansetron. Foreign matter should not be present in a sterile injectable product.
Continue reading...28. May 2010
Comments Off
Product contains substances which are poisonous when ingested or applied to large areas of the body.
Continue reading...26. May 2010
Comments Off
Voluntary recall of all manufactured lots has been initiated as a precautionary measure due to instances of particulate matter observed in a limited number of vials during routine stability testing.
Continue reading...26. May 2010
Comments Off
Revised labeling to include cases of severe liver injury.
Continue reading...25. May 2010
Comments Off
Possible increased risk of fractures of the hip, wrist, and spine.
Continue reading...25. May 2010
Comments Off
Risk of overdosage or suicide for patients who are addiction-prone, taking tranquilizers or antidepressant drugs.
Continue reading...17. May 2010
Comments Off
Non-sterility of metronidazole injection administered via the intravenous route has the potential to result in infections, which could be fatal.
Continue reading...16. May 2010
Comments Off
UPDATE 05/16/2010. FDA determined it is appropriate for clinicians and health care professionals to resume the use of Rotarix and to continue the use of RotaTeq. Originally posted 03/22/2010
Continue reading...13. May 2010
Comments Off
Defective control board wiring harnesses can cause the machine to unexpectedly shut down, terminating ventilation, anesthetic delivery, and potentially patient monitoring.
Continue reading...
28. May 2010
Comments Off